Cargando…
Rapid development of vaccines against emerging pathogens: The replication-deficient simian adenovirus platform technology
Despite the fact that there had been multiple small outbreaks of Ebola Virus Disease, when a large outbreak occurred in 2014 there were no vaccines or drugs available for use. Clinical development of multiple candidate vaccines was then initiated in parallel with attempts to contain the outbreak but...
Autores principales: | Gilbert, Sarah C., Warimwe, George M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Authors. Published by Elsevier Ltd.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5571606/ https://www.ncbi.nlm.nih.gov/pubmed/28576573 http://dx.doi.org/10.1016/j.vaccine.2017.04.085 |
Ejemplares similares
-
Simian adenoviruses as vaccine vectors
por: Morris, Susan J, et al.
Publicado: (2016) -
Protective efficacy of a novel simian adenovirus vaccine against lethal MERS-CoV challenge in a transgenic human DPP4 mouse model
por: Munster, Vincent J., et al.
Publicado: (2017) -
Adenovirus-based vaccines—a platform for pandemic preparedness against emerging viral pathogens
por: Coughlan, Lynda, et al.
Publicado: (2022) -
Development of a novel simian adenovirus 24 based vaccine vector
por: Abbink, P, et al.
Publicado: (2012) -
A novel oncolytic adenovirus based on simian adenovirus serotype 24
por: Cheng, Tao, et al.
Publicado: (2017)